Uncategorised
Wojciech Karwatowski is elected chair of the Clinical Council for Eye Health Commissioning
Congratulations to Wojciech Karwatowski who has been elected as the new chair of the Clinical Council for Eye Health Commissioning (CCEHC) following a vote by the members of the Clinical Council. Wojciech is a consultant ophthalmologist at University Hospitals of Leicester NHS Trust, Chair of the Local Eye Health Network for Leicestershire and Lincolnshire and is also
The College of Optometrists and The Royal College of Ophthalmologists launch NEW joint vision for delivering eye care services across the UK
The College of Optometrists and The Royal College of Ophthalmologists (RCOphth) continue to review the ongoing impact of the pandemic on eye services across primary and secondary care. Following on from the joint vision statement for England published in August 2020, both Colleges have reviewed and built on the learnings over the past year resulting
RCOphth launches guidance on Low Vision: the essential guide for ophthalmologists
This excellent guidance will help ophthalmologists answer questions they may have when presented with patients with low vision needs, such as “Which patients should be referred to low vision services?”, or “Is there a level of visual acuity below which a patient should be referred?” As in referral for cataract surgery, it depends on the
CCEHC survey highlights need for low vision services review
The Clinical Council for Eye Health Commissioning (CCEHC) which represents the major clinical professions and sight loss charity organisations in the eye-care sector, has conducted a survey on the commissioning and provision of low vision assessment services in England. The survey was conducted for five weeks from 5th April 2021 to gain an understanding of the impact
Drugs Shortage: Continuing shortage of Visudyne (verteporfin)
The College has been made aware that the manufacturers of Visudyne (verteporfin) are experiencing significant production delays and new stocks of Visudyne will not be available for the UK market until early 2022. Due to the low volume of circulating stock of Visudyne in the UK the Department of Health and Social Care has made